ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University
[Plasma metabolomics combined with machine learning for classifying ischemic stroke subtypes and predicting the etiology of cryptogenic stroke].
Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectivesTo analyze plasma metabolic profiles of different ischemic stroke subtypes and construct machine learning (ML)-based models to identify these subtypes for accurate diagnosis of cryptogenic stroke.
methodsA total of 277 patients with acute ischemic stroke (AIS) from 3 hospitals were prospectively enrolled and stratified according to the TOAST classification criteria. Venous blood samples were collected for ¹H-NMR metabolomics detection, resulting in the identification of 46 metabolites. Metabolomics and Mendelian randomization analyses were employed to identify the potential biomarkers, and PyCaret was used to develop and optimize the ML models. A Plasma Metabolite Machine Learning (PMML) model was developed to differentiate the ischemic stroke subtypes, and the efficacy of the model was validated using a cryptogenic stroke (SUE) cohort.
resultsSignificantly different metabolite profiles were observed among patients with large artery atherosclerosis (LAA), small vessel occlusion (SVO), and cardioembolism (CE). Mendelian randomization analysis indicated that glucose and proline may serve as potential biomarkers for SVO and LAA. The PMML model developed based on the metabolic profiles of LAA, SVO, and CE demonstrated a high predictive accuracy for distinguishing these ischemic stroke subtypes with an accuracy of 0.8630 and an area under the ROC curve of 0.9586. In the SUE patients (the validation cohort), 23.9% of the patients predicted to have LAA exhibited vulnerable plaques, as compared with a rate of 10.9% in those predicted to have SVO or CE. Five patients predicted to have CE were diagnosed with paroxysmal atrial fibrillation via long-term electrocardiographic monitoring.
conclusionsDifferent ischemic stroke subtypes have distinct plasma metabolic profiles. The PMML model developed based on plasma metabolic features of the 3 well-diagnosed stroke subtypes demonstrates a high accuracy in identifying these subtypes with a great potential for predicting the etiology of cryptogenic stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.